|
Home >> Clinical Trials >> Physician Information
The NeuroThera ® system is currently undergoing a clinical trial investigation called the NeuroThera Effectiveness and Safety Trial-2 (NEST-2). For further information, and/or interest in participating as a site in NEST-2, please contact PhotoThera ® directly at 760.496.3700 or email info@photothera.com.
References:
- Lampl Y, Zivin JA, Fisher M, Lew R, Welin L, Dahlof B, Borenstein P, Andersson B, Perez J, Caparo C, Ilic S, and Oron U. Infrared Laser Therapy for Ischemic Stroke: A New Treatment Strategy: Results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1). Stroke. Jun 2007; 38: 1843 - 1849.
- Desmet KD, Paz DA, Corry JJ, Eella JT, Wong-Riley MTT, Henry MM, Buchmann EV, Connelly MP, Dovi JV, Liang HL, Henshel DS., Yeager RL, Millsap DS., Lim J, Gould LJ, Das R, Jett M, Hodgson BD, Margolis D, and Whelan HT. Clinical and Experimental Applications of NIR-LED Photobiomodulation. Photomedicine and Laser Surgery. 2006;24(2):121-128
- Eells JT, Henry MM, Summerfelt P, Wong-Riley MTT, Buchmann EV, Kane M, Whelan NT and Whelan HT. Therapeutic Photobiomodulation for Methanol-Induced Retinal Toxicity. PNAS. 2003;100(6):3439-3444
- Karu T. Mechanisms of low-power laser light action on cellular level. Proceedings of SPIE; 2000; 4159: 1-17.
- Lapchak PA, Wei J, and Zivin JA. Transcranial Infrared Laser Therapy Improves Clinical Rating Scores After Embolic Strokes in Rabbits. Stroke. 2004; 35:1985-1988
- Oron A, Oron U, Chen J, Eilam A, Zhang C, Sadeh M, Lampl Y, Streeter J, DeTaboada L, and Chopp M. Low-Level Laser Therapy Applied Transcranially to Rats After Induction of Stroke Significantly Reduces Long-Term Neurological Deficits. Stroke. 2006; 37:2620-2624.
- Streeter J, De Taboada L, and Oron U. Mechanisms of Action of Light Therapy for Stroke and Acute Myocardial Infarction. Elsevier B.V. and Mitochondria Research Society. 2004; 4:569-576
Additional References are listed under Resources and Links
|
|
